STATEWIDE CANCER DATA SHARED RESOURCE Statewide Cancer Data (SCD) is a two component SR that combines Rapid Case Ascertainment (RCA) and the Cancer Information and Population Health Resource (CIPHR). This resource reflects a commitment of the cancer center and of the CPC, CR, BC and CE Programs to support research in real-world populations with a focus on disparities and access to care ? particularly in the state of North Carolina. A strong relationship between RCA and the North Carolina Central Cancer Registry (CCR), and the hospital tumor registrars allows RCA to facilitate population-based studies of cancer for Lineberger Cancer Center and outside investigators. For rapid case ascertainment, the Central Cancer Registry utilizes RCA personnel, and proactively requests and obtains diagnostic information within one month of the patient?s diagnosis. The other component of this resource is CIPHR, which includes cancer case data from CCR linked to healthcare administrative claims data from Medicare, Medicaid, and private insurance. The resulting claims dataset represents over 8 million individuals. Beneficiaries are reconciled across payers and linked to approximately 750,000 North Carolina cancer cases from the last decade. The size and complexity of the population-based datasets created and housed by this resource require an interdisciplinary staff to successfully and efficiently manage, analyze, and understand the data. SR staff apply diverse and innovative data management and analytic methods many specifically created for CIPHR to answer important population-based questions about the LCCC catchment area. Linkage of LCCC population-based cohorts has been accomplished. Researcher support from SCD typically extends from development of the initial research question, gathering preliminary data for grant applications through cohort discovery, statistical analysis, and manuscript writing. In FY2019, 37 LCCC members representing 93% of users used the SCD SR. This is a cost-effective mechanism to both collect cancer cases efficiently across the state and to disseminate that information. Since CIPHR began linking to Medicare data in 2012, it has been extensively used by faculty, trainees, and various collaborators both within UNC and at other cancer centers. To date, more than $15M in external funding has been enabled by this shared resource. The SCD requests $206,586 from the CCSG, which is 12% of the total FY20 $1.8 M operating budget, $900,000 of which is provided by the LCCC.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA016086-45
Application #
10089836
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
1997-06-01
Project End
2025-11-30
Budget Start
2020-12-01
Budget End
2021-11-30
Support Year
45
Fiscal Year
2021
Total Cost
Indirect Cost
Name
University of North Carolina Chapel Hill
Department
Type
DUNS #
608195277
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
Cai, Ling; Tsai, Yi-Hsuan; Wang, Ping et al. (2018) ZFX Mediates Non-canonical Oncogenic Functions of the Androgen Receptor Splice Variant 7 in Castrate-Resistant Prostate Cancer. Mol Cell 72:341-354.e6
Moschos, Stergios J; Sullivan, Ryan J; Hwu, Wen-Jen et al. (2018) Development of MK-8353, an orally administered ERK1/2 inhibitor, in patients with advanced solid tumors. JCI Insight 3:
Brosnan, Evelyn M; Anders, Carey K (2018) Understanding patterns of brain metastasis in breast cancer and designing rational therapeutic strategies. Ann Transl Med 6:163
Valle, Carmina G; Queen, Tara L; Martin, Barbara A et al. (2018) Optimizing Tailored Communications for Health Risk Assessment: A Randomized Factorial Experiment of the Effects of Expectancy Priming, Autonomy Support, and Exemplification. J Med Internet Res 20:e63
Sun, Junjiang; Shao, Wenwei; Chen, Xiaojing et al. (2018) An Observational Study from Long-Term AAV Re-administration in Two Hemophilia Dogs. Mol Ther Methods Clin Dev 10:257-267
Wilczewski, Caralynn M; Hepperla, Austin J; Shimbo, Takashi et al. (2018) CHD4 and the NuRD complex directly control cardiac sarcomere formation. Proc Natl Acad Sci U S A 115:6727-6732
Waters, Andrew M; Der, Channing J (2018) KRAS: The Critical Driver and Therapeutic Target for Pancreatic Cancer. Cold Spring Harb Perspect Med 8:
Gralinski, Lisa E; Sheahan, Timothy P; Morrison, Thomas E et al. (2018) Complement Activation Contributes to Severe Acute Respiratory Syndrome Coronavirus Pathogenesis. MBio 9:
Au, Kin Man; Tripathy, Ashutosh; Lin, Carolina Pe-I et al. (2018) Bespoke Pretargeted Nanoradioimmunotherapy for the Treatment of Non-Hodgkin Lymphoma. ACS Nano 12:1544-1563
Mirlekar, Bhalchandra; Michaud, Daniel; Searcy, Ryan et al. (2018) IL35 Hinders Endogenous Antitumor T-cell Immunity and Responsiveness to Immunotherapy in Pancreatic Cancer. Cancer Immunol Res 6:1014-1024

Showing the most recent 10 out of 1525 publications